CaremaP
ActiveSummary
CaremaP has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €45,515 and a net result of €16,746. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 65% of 34,483 sector peers (NACE 43, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
19-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2018 to 2025net €26,683 ▲106%
Operating result €39,266, net result €26,683, both a record.
28-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
28-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Back to profitnet €9,764
Net result €9,764 after 3 loss-making years.
29-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
30-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
30-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-12
Financial
Weakest financial yearnet -€13,354
Net result drops to -€13,354, the lowest in the series; recovery starts the following year.
28-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
27-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
30-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all 12 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.